Following is a listing of executive and legislative action for the week of Sept. 14. The state House of Representatives was in session at press time. The Pennsylvania Senate was in recess and was scheduled to return Monday.

COVID-19 Drug

Pennsylvania Treasurer Joe Torsella is urging the pharma company Gilead Sciences to reconsider its pricing of remdesivir, the only antiviral drug authorized by the U.S. Food and Drug Administration to treat cases of COVID-19.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]